Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.52 CAD | +1.33% | +1.33% | +4.83% |
May. 28 | Zentek Gaining Tuesday After Receiving Patent in Canada for Its Antimicrobial Compound | MT |
May. 27 | Zentek Up 2.7% As Says Granted Second Patent from the Canadian Intellectual Patent Office | MT |
Sales 2022 | 0.35 0.48 | Sales 2023 | 0.07 0.1 | Capitalization | 206M 284M |
---|---|---|---|---|---|
Net income 2022 | -38M -52.3M | Net income 2023 | -14M -19.27M | EV / Sales 2022 | 1,031,593,065 x |
Net cash position 2022 | 24.44M 33.64M | Net cash position 2023 | 8.75M 12.04M | EV / Sales 2023 | 2,707,984,696 x |
P/E ratio 2022 |
-9.19
x | P/E ratio 2023 |
-14.3
x | Employees | 29 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.07% |
1 day | +1.33% | ||
1 week | +1.33% | ||
Current month | +1.33% | ||
1 month | +4.11% | ||
3 months | -8.98% | ||
6 months | +5.56% | ||
Current year | +4.83% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Fenton
CEO | Chief Executive Officer | - | 18-07-10 |
Wendy Ford
DFI | Director of Finance/CFO | - | 22-05-15 |
Adam MacIntosh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ilse Treurnicht
BRD | Director/Board Member | - | 22-07-04 |
John Snisarenko
BRD | Director/Board Member | 61 | 23-10-04 |
Francis Dubé
BRD | Director/Board Member | - | 18-05-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.52 | +1.33% | 98,213 |
24-06-06 | 1.5 | 0.00% | 78,867 |
24-06-05 | 1.5 | -3.23% | 70,350 |
24-06-04 | 1.55 | -2.52% | 40,903 |
24-06-03 | 1.59 | +6.00% | 56,356 |
Delayed Quote Toronto S.E., June 07, 2024 at 03:59 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.83% | 111M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ZEN Stock